Ligand Pharma (LGND) PT Raised to $182 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright raised its price target on Ligand Pharma (NASDAQ: LGND) to $182.00 (from $170.00) while maintaining a Buy rating.Analsyt ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
